The Infection Control Today® prevention page contains news and information on the latest updates on all facets of infection prevention. From vaccinations and immunizations to controlling air and water flow in a health care system, preventing infections falls not only on the infection prevention staff, but on all who interact within the hospital, from environmental services teams to those planning and building new construction.
April 30th 2024
Noah Wald-Dickler, MD, FACP, discusses the safety and efficacy of oral transition therapy, challenges in antimicrobial stewardship, and evidence-based alternatives presented at SHEA 2024.
Medical Crossfire®: Maximizing Patient Outcomes in Shingles – Are You Leveraging Guideline Based Care?
View More
Understanding RSV: What You Need to Know to Prevent and Treat Respiratory Syncytial Virus in Your Patients
View More
Respiratory Syncytial Virus: Understanding the Infection Burden and Anticipating the Impact of Vaccines
View More
Medical Crossfire®: Which Patients with Hematologic Malignancies are at Risk for Secondary Immunodeficiency (SID)… and How Can We Leverage Evidence to Improve Their Outcomes?
View More
Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations
View More
Vaccination Insights From NFID Medical Director: Preventing Respiratory Diseases in Pregnancy
December 1st 2023Learn about vital vaccination recommendations during pregnancy to prevent respiratory diseases like RSV, COVID-19, and influenza. NFID's Robert H. Hopkins, Jr. MD, offers insights and strategies for effective communication.
Understanding Infection Risks for Patients With Diabetes During Diabetes Awareness Month
November 30th 2023Diabetes Awareness Month in November highlights the heightened susceptibility of diabetes patients to infections. Explore the key reasons behind their increased infection risk and the importance of infection prevention.
About the Infection Control Today's Educator of the Year Award
November 24th 2023Infection Control Today® is honored to announce it is reviving the Infection Control Today’s Educator of the Year Award™. For more information, please listen to Linda Spaulding, RN, CIC, the 2023 Winner of the Infection Control Today’s Educator of the Year Award.
Uncovering the Hidden Dangers: A Comprehensive Study on Insulated Medical Devices From 2021 to 2022
November 21st 2023This interview with Cheron Rojo, BS, FCS, CHL, CIS, CER, CFER, CRCST, delves into a robust year-long study, starting in 2021, investigating the often-overlooked risks associated with insulated medical devices impacting both patients and medical staff.
Direct Gloving vs Hand Hygiene Before Donning Gloves: A Hospital Infection Control Study
November 20th 2023Read about a cluster randomized clinical trial that found that direct gloving without prior hand hygiene significantly improved infection prevention practice adherence among health care personnel.
CDC's Recommendation for Hepatitis C Testing in Infants Exposed During Perinatal Period
November 13th 2023The CDC recommends HCV testing for perinatally exposed infants and children to address the increasing incidence of hepatitis C among reproductive-age individuals, focusing on early detection and appropriate care.
Hot Topics in IPC: Influenza, COVID-19, and Mechanical Ventilation and Drug-Resistant Pathogens
November 3rd 2023In this Hot Topics in IPC, Saskia v. Popescu, PhD, MPH, MA, CIC, FAPIC, discusses her concerns about COVID-19 and influenza for this winter, and mechanical ventilation and drug-resistant pathogens.
Qnovia Collaborates With UVA to Develop Novel Inhaled Therapies for Lung Infections
November 1st 2023Pharmaceutical company Qnovia partners with the University of Virginia (UVA) to create inhaled drugs for lung infections, bolstering their development pipeline with assets for pneumonia and biodefense-related pulmonary infections.
CDC Advises on Limited Nirsevimab Supply and RSV Protection Options
October 31st 2023The Centers for Disease Control and Prevention is advising providers to prioritize 100 mg doses of nirsevimab, a monoclonal antibody FDA-approved to prevent respiratory syncytial virus (RSV), for infants at the highest risk of severe RSV disease.
Handheld UV-C Technology: A Solution to Combat Health Care-Associated Infections
October 26th 2023A study led by Piyali Chatterjee, PhD, and the Central Texas Veterans Health Care System explores the potential of handheld filtered Far UV-C devices in reducing hospital-acquired infections. Freestyle Partners, LLC, supported this research.
Overcoming Challenges to Eye Device Reprocessing: A 3-Year Study
October 25th 2023A recent American Journal of Infection Control study, led by Katharine Hoffman, MPH, CIC, LSSGB, and Lisa Waldowski, DNP, RN, CIC, applies Lean Six Sigma to improve eye device reprocessing. The research highlights the challenges, emphasizes adherence to manufacturer instructions, and promotes best practices for patient safety.